Pharmaceuticals - Community Register

  

List of nationally authorised medicinal products for human use

Sortis

Product name: Sortis
Also marketed in the EU under the name(s): Atorvastatin, Atorvastatina, Cardyl, Edovin, Lipitor, Liprimar, Obradon, Orbeos, Prevencor, Tahor, Texzor, Torvast, Totalip, Xarator, Zarator
Active substance: Atorvastatin
Indication: Indicated as an adjunct to diet for reduction of elevated total cholesterol, to reduce total-C and LDL-C in patients adults with homozygous familial hypercholesterolaemia. Prevention of cardiovascular events in adult patients
Marketing Authorisation Holder: Pfizer Limited

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/07/2010 Referral EMEA/H/A-29/PAD/1253, A-29/PAD/1254, A-29/PAD/1255 (2010)4677 of 01/07/2010